BOSTON, Mass.--(BUSINESS WIRE)--Oslo Cancer Cluster today announced at BIO2007 that Bristol-Myers Squibb Norway is the latest leading pharmaceutical company to join this major private-public initiative in one of Europe’s rising biopharma regions. Established around the Radium Hospital, which has the same Comprehensive Cancer Center status as leading US institutions as Dana Farber, MD Anderson and Sloan Kettering, the Oslo Cancer Cluster aims to become the most innovative center in Europe for cancer diagnostics and treatment by 2015. BIO2007 comes in the middle of a launch visit to the US which includes presentations in Research Triangle Park and Boston.
